China Resources Boya Bio pharmaceutical Group Co Ltd
China Resources Boya Bio-pharmaceutical Group Co.,Ltd engages in the blood product businesses in China. It offers blood products, such as human coagulation, human prothrombin, human fibrinogen, human albumin, intravenous human immunoglobulin, and rabies immunoglobulin; and non-blood products. The company also provides bone peptide, oxytocin, heparin sodium, and posterior pituitary injection produ… Read more
China Resources Boya Bio pharmaceutical Group Co Ltd (300294) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.006x
Based on the latest financial reports, China Resources Boya Bio pharmaceutical Group Co Ltd (300294) has a cash flow conversion efficiency ratio of 0.006x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥43.70 Million) by net assets (CN¥7.67 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
China Resources Boya Bio pharmaceutical Group Co Ltd - Cash Flow Conversion Efficiency Trend (2009–2024)
This chart illustrates how China Resources Boya Bio pharmaceutical Group Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
China Resources Boya Bio pharmaceutical Group Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of China Resources Boya Bio pharmaceutical Group Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Shenzhen Desay Battery Technology Co Ltd
SHE:000049
|
0.015x |
|
Amerant Bancorp Inc.
NYSE:AMTB
|
0.024x |
|
Servyou Software Group Co Ltd
SHG:603171
|
N/A |
|
Chongqing Taiji Industry Group Co Ltd
SHG:600129
|
0.015x |
|
Butterfly Network Inc
NYSE:BFLY
|
-0.014x |
|
Jiangsu Shemar Electric Co Ltd
SHG:603530
|
0.049x |
|
PixArt Imaging
TWO:3227
|
0.057x |
|
Pantoro Gold Ltd
AU:PNR
|
0.247x |
Annual Cash Flow Conversion Efficiency for China Resources Boya Bio pharmaceutical Group Co Ltd (2009–2024)
The table below shows the annual cash flow conversion efficiency of China Resources Boya Bio pharmaceutical Group Co Ltd from 2009 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥7.49 Billion | CN¥299.78 Million | 0.040x | -54.33% |
| 2023-12-31 | CN¥7.32 Billion | CN¥641.73 Million | 0.088x | +7.06% |
| 2022-12-31 | CN¥7.28 Billion | CN¥596.44 Million | 0.082x | -57.88% |
| 2021-12-31 | CN¥6.92 Billion | CN¥1.35 Billion | 0.194x | +13.42% |
| 2020-12-31 | CN¥4.19 Billion | CN¥718.58 Million | 0.171x | +697.00% |
| 2019-12-31 | CN¥3.99 Billion | CN¥-114.51 Million | -0.029x | -410.15% |
| 2018-12-31 | CN¥3.77 Billion | CN¥34.90 Million | 0.009x | +196.56% |
| 2017-12-31 | CN¥2.48 Billion | CN¥-23.82 Million | -0.010x | -110.28% |
| 2016-12-31 | CN¥2.13 Billion | CN¥198.76 Million | 0.093x | +20.98% |
| 2015-12-31 | CN¥1.91 Billion | CN¥147.02 Million | 0.077x | -41.59% |
| 2014-12-31 | CN¥923.93 Million | CN¥121.88 Million | 0.132x | +25.34% |
| 2013-12-31 | CN¥846.62 Million | CN¥89.11 Million | 0.105x | -14.35% |
| 2012-12-31 | CN¥751.60 Million | CN¥92.36 Million | 0.123x | -60.41% |
| 2011-12-31 | CN¥262.67 Million | CN¥81.53 Million | 0.310x | +147.44% |
| 2010-12-31 | CN¥197.44 Million | CN¥24.77 Million | 0.125x | -60.23% |
| 2009-12-31 | CN¥164.49 Million | CN¥51.88 Million | 0.315x | -- |